Kyriakos Saad, Melissa, El Hachem, George, Chahine, Claude, Chahine, Elias, Saikaly, Elias. (1400). Time Will Tell: the Short Term Gain and the Long Term Loss: Bariatric Surgery and Colorectal Cancer. سامانه مدیریت نشریات علمی, 10(1), 1-4. doi: 10.30476/acrr.2022.94393.1129
Melissa Kyriakos Saad; George El Hachem; Claude Chahine; Elias Chahine; Elias Saikaly. "Time Will Tell: the Short Term Gain and the Long Term Loss: Bariatric Surgery and Colorectal Cancer". سامانه مدیریت نشریات علمی, 10, 1, 1400, 1-4. doi: 10.30476/acrr.2022.94393.1129
Kyriakos Saad, Melissa, El Hachem, George, Chahine, Claude, Chahine, Elias, Saikaly, Elias. (1400). 'Time Will Tell: the Short Term Gain and the Long Term Loss: Bariatric Surgery and Colorectal Cancer', سامانه مدیریت نشریات علمی, 10(1), pp. 1-4. doi: 10.30476/acrr.2022.94393.1129
Kyriakos Saad, Melissa, El Hachem, George, Chahine, Claude, Chahine, Elias, Saikaly, Elias. Time Will Tell: the Short Term Gain and the Long Term Loss: Bariatric Surgery and Colorectal Cancer. سامانه مدیریت نشریات علمی, 1400; 10(1): 1-4. doi: 10.30476/acrr.2022.94393.1129
Time Will Tell: the Short Term Gain and the Long Term Loss: Bariatric Surgery and Colorectal Cancer
1Department of Visceral and Digestive Surgery, Centre Hospitalier Sud Francilien, Corbeil Essones, Franc.
2Department of Medical Oncology, Saint George Hospital University Medical Center, Beirut, Lebanon, University of Balamand, Lebanon
3Department International d’oncologie, Gustave Roussy, Universite Paris-Saclay, Villejuif, Fran
4Department of Minimally Invasive Surgery, Poissy Saint Germain Medical Center, Poissy, Fran
5Department of General Surgery, Saint George Hospital University Medical Center, Beirut, Lebanon.
چکیده
Obesity is a growing worldwide epidemic and its prevalence is in a continuous rise. Bariatric and metabolic surgery is the most effective treatment modality for long-term weight loss and resolution of associated comorbidities. It is well known that obesity increases the overall mortality and the link between obesity and the increased risk of cancer is firmly established, mainly hormone related cancers such as breast cancer and endometrial cancer. On the other hand, the association between intentional weight reduction through bariatric or metabolic surgery and the reduced cancer risk, mainly none hormone mediated cancers remains poorly understood with limited knowledge and conflicting data in the medical literature. Furthermore, the published outcomes regarding the effect of bariatric and metabolic surgery on the risk of colorectal cancer suggest a complex and poorly understood association. We herein review the literature regarding such an association and provide a plausible mechanism behind the increased risk of colorectal cancer after bariatric and metabolic surgery.
Derogar M, Hull MA, Kant P, et al. Increased risk of colorectal cancer after obesity surgery. Ann Surg. 2013;258:983–8.
Tao W, Artama M, von Euler-Chelpin M, Hull M, Ljung R. Colon and rectal cancer risk after bariatric surgery in a multicountry Nordic cohort study. 2019
Hussan H, Drosdak A, Le Roux M, et al. The long-term impact of Roux-En-Y gastric bypass on colorectal polyp formation and relation to weight loss outcomes. Obes Surg. 2019
Afshar, S. et al. The effects of bariatric surgery on colorectal cancer risk: systematic review and meta-analysis. Obes. Surg. 24, 1793–1799 (2014)
Aravani, A. et al. Obesity surgery and risk of colorectal and other obesity-related cancers: an English population-based cohort study. Cancer Epidemiol. 53, 99–104 (2018)
Mackenzie, H. et al. Obesity surgery and risk of cancer. Br. J. Surg. (2018)
Kant P, Sainsbury A, Reed KR, et al. Rectal epithelial cell mitosis and expression of macrophage migration inhibitory factor are increased 3 years after Roux-en-Y gastric bypass (Rygb) for morbid obesity: implications for long-term neoplastic risk following Rygb. Gut. 2011;60:893–901
Sainsbury A, Goodlad RA, Perry SL, et al. Increased colorectal epithelial cell proliferation and crypt fission associated with obesity and Roux-en-Y gastric bypass. Cancer Epidemiol Biomark Prev. 2008;17:1401–10
Anhe FF, Varin TV, Schertzer JD, et al. The gut microbiota as a mediator of metabolic benefits after bariatric surgery. Can J Diabetes. 2017;41:439–47
Palleja A, Kashani A, Allin KH, et al. Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota. GenomeMed.2016;8:67
Hussan H, Clinton SK, Roberts K, et al. Fusobacterium's link to colorectal Neoplasia sequenced: a systematic review and future insights. World J Gastroenterol. 2017;23:8626–50
LiJV, Reshat R,Wu Q, etal.Experimental bariatric surgery in rats generates a cytotoxic chemical environment in the gut contents. Front Microbiol. 2011;2:183
Quan H, Parsons GA, Ghali WA. Validity of procedure codes in international classification of diseases, 9th revision, clinical modification administrative data. Med Care. 2004;42:801–9
Tremaroli V, Karlsson F, Werling M, et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab. 2015;22(2):228–38
O'Keefe SJ, Li JV, Lahti L. Fat, fibre and cancer risk in African Americans and rural Africans 2015;6:6342.
